2017
DOI: 10.1111/cea.12882
|View full text |Cite
|
Sign up to set email alerts
|

Vaccination management in children and adults with mastocytosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
48
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(54 citation statements)
references
References 9 publications
(26 reference statements)
1
48
0
Order By: Relevance
“…1,2 These patients experienced mild reactions that did not require hospitalization nor recur with subsequent vaccinations. 1,2 However, the dermatology literature has yet to comment on this phenomenon. Here, we aim to determine the prevalence of vaccination reactions in patients with pediatric cutaneous mastocytosis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,2 These patients experienced mild reactions that did not require hospitalization nor recur with subsequent vaccinations. 1,2 However, the dermatology literature has yet to comment on this phenomenon. Here, we aim to determine the prevalence of vaccination reactions in patients with pediatric cutaneous mastocytosis.…”
Section: Introductionmentioning
confidence: 99%
“…Some MPCM patients experience symptoms due to the release of mediators from mast cells including flushing, pruritus, gastrointestinal upset, and anaphylaxis. Recently, the allergy and immunology literature has published data showing there may be a relationship between routine vaccinations and induction of symptoms in patients with cutaneous mastocytosis 1‐3 . Two retrospective studies found a higher rate of adverse reactions to vaccinations in children with all types of mastocytosis, including MPCM, when compared to the general population 1,2 .…”
Section: Introductionmentioning
confidence: 99%
“…Patients who reported a reaction to constituents of the vaccine or idiopathic anaphylaxis may also be at risk of AEFI, and therefore require an allergologist's evaluation to decide for subsequent vaccination schedule and setting. In patients with mastocytosis it is suggested to perform vaccination with single products and to extend observation time to 30 minutes at least, but a controlled setting is not usually required (28,70). Specific IgE antibodies to vaccine antigens are useless in the case of suspect hypersensitivity to the vaccine as they are produced in the normal immune response to immunisation, as mentioned above (43).…”
Section: Discussionmentioning
confidence: 99%
“…31 They saw very few reactions and only recommend extending the normal 15-minute observation period to 30 minutes along with training for parents in how to recognize and manage allergic reactions. 31 They saw very few reactions and only recommend extending the normal 15-minute observation period to 30 minutes along with training for parents in how to recognize and manage allergic reactions.…”
Section: Anaphylaxismentioning
confidence: 99%
“…Zanoni and colleagues have looked at rates of vaccine reactions in their mastocytosis clinic. 31 They saw very few reactions and only recommend extending the normal 15-minute observation period to 30 minutes along with training for parents in how to recognize and manage allergic reactions.…”
Section: Anaphylaxismentioning
confidence: 99%